New Lymphoma Drug Shows Promise
Eleven of 38 non-Hodgkin patients respond to blinatumomab, study finds
More Cancer Lymph Nodes Analyzed at Specialty Centers
If too few are tested, patient's treatment and prognosis may be affected, study says
Incidence of Mantle Cell Lymphoma on Rise
Aggressive form of non-Hodgkin disease puts older men chiefly at risk, study finds
Scientists Find Way to Dim Cancer Switch
Research could pave the way for better treatments of certain malignancies
Research Uncovers Clues to Lymphoma
Findings from mouse model could lead to new therapeutic targets
Young Hodgkin Survivors Face Later Risk of Second Cancers
Thyroid, breast, non-Hodgkin lymphoma were the most common types, study says
Hodgkin Lymphoma Kids Face Greater Risk of Future Problems
Breast cancer leading cause of death for female survivors; cardiovascular events for males
Medicare Costs Soar for Cancer Care
Expenditures will continue to rise as the population ages, experts say
Radioimmunotherapy After Chemo Safe for Common Lymphoma
Combo treatment improved overall survival rates in follicular non-Hodgkin lymphoma
Outcomes Improve for Non-Hodgkin Lymphoma Patients
Survival rates have increased, likely because of advancements in therapy
| < Previous | Next > |
Copyright © 2010 Cox Ohio Publishing, Dayton, Ohio, USA. All rights reserved.
By using this site, you accept the terms of our Visitors Agreement and Privacy Policy. You may wish to note our other business policies.